Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor

Chantale Charo, Vijaykumar Holla, Thiruvengadam Arumugam, Rosa Hwang, Peiying Yang, Raymond N. Dubois, David G. Menter, Craig D. Logsdon, Vijaya Ramachandran

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

OBJECTIVES: Pancreatic stellate cells are source of dense fibrotic stroma, a constant pathological feature of chronic pancreatitis and pancreatic adenocarcinoma. We observed correlation between levels of cyclooxygenase 2 (COX-2) and its product prostaglandin E2 (PGE2) and the extent of pancreatic fibrosis. The aims of this study were to delineate the effects of PGE2 on immortalized human pancreatic stellate cells (HPSCs) and to identify the receptor involved. METHODS: Immunohistochemistry, reverse transcription- polymerase chain reaction and quantitative reverse transcription-polymerase chain reaction were used to assess COX-2, extracellular matrix, and matrix metalloproteinase gene expression. Eicosanoid profile was determined by liquid chromatography-tandem mass spectrometry. Human pancreatic stellate cell proliferation was assessed by MTS assay, migration by Boyden chamber assay, and invasion using an invasion chamber. Transient silencing was obtained by small interfering RNA. RESULTS: Human pancreatic stellate cells express COX-2 and synthesize PGE2. Prostaglandin E2 stimulated HPSC proliferation, migration, and invasion and stimulated expression of both extracellular matrix and matrix metalloproteinase genes. Human pancreatic stellate cells expressed all 4 EP receptors. Only blocking the EP4 receptor resulted in abrogation of PGE2-mediated HPSC activation. Specificity of EP4 for the effects of PGE2 on stellate cells was confirmed using specific antagonists. CONCLUSIONS: Our data indicate that PGE2 regulates pancreatic stellate cell profibrotic activities via EP4 receptor, thus suggesting EP4 receptor as useful therapeutic target for pancreatic cancer to reduce desmoplasia.

Original languageEnglish (US)
Pages (from-to)467-474
Number of pages8
JournalPancreas
Volume42
Issue number3
DOIs
StatePublished - Apr 2013
Externally publishedYes

Fingerprint

Pancreatic Stellate Cells
Dinoprostone
Cyclooxygenase 2
Matrix Metalloproteinases
Reverse Transcription
Extracellular Matrix
Cell Proliferation
Polymerase Chain Reaction
Eicosanoids
Chronic Pancreatitis
Tandem Mass Spectrometry
Pancreatic Neoplasms
Liquid Chromatography
Small Interfering RNA
Cell Movement
Adenocarcinoma
Fibrosis
Immunohistochemistry
Gene Expression

Keywords

  • EP4 receptor
  • Pancreatic cancer
  • Pancreatic stellate cells
  • PGE

ASJC Scopus subject areas

  • Hepatology
  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Charo, C., Holla, V., Arumugam, T., Hwang, R., Yang, P., Dubois, R. N., ... Ramachandran, V. (2013). Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor. Pancreas, 42(3), 467-474. https://doi.org/10.1097/MPA.0b013e318264d0f8

Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor. / Charo, Chantale; Holla, Vijaykumar; Arumugam, Thiruvengadam; Hwang, Rosa; Yang, Peiying; Dubois, Raymond N.; Menter, David G.; Logsdon, Craig D.; Ramachandran, Vijaya.

In: Pancreas, Vol. 42, No. 3, 04.2013, p. 467-474.

Research output: Contribution to journalArticle

Charo, C, Holla, V, Arumugam, T, Hwang, R, Yang, P, Dubois, RN, Menter, DG, Logsdon, CD & Ramachandran, V 2013, 'Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor', Pancreas, vol. 42, no. 3, pp. 467-474. https://doi.org/10.1097/MPA.0b013e318264d0f8
Charo C, Holla V, Arumugam T, Hwang R, Yang P, Dubois RN et al. Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor. Pancreas. 2013 Apr;42(3):467-474. https://doi.org/10.1097/MPA.0b013e318264d0f8
Charo, Chantale ; Holla, Vijaykumar ; Arumugam, Thiruvengadam ; Hwang, Rosa ; Yang, Peiying ; Dubois, Raymond N. ; Menter, David G. ; Logsdon, Craig D. ; Ramachandran, Vijaya. / Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor. In: Pancreas. 2013 ; Vol. 42, No. 3. pp. 467-474.
@article{83c8ca390cae49c2a5c9b96a7232feeb,
title = "Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor",
abstract = "OBJECTIVES: Pancreatic stellate cells are source of dense fibrotic stroma, a constant pathological feature of chronic pancreatitis and pancreatic adenocarcinoma. We observed correlation between levels of cyclooxygenase 2 (COX-2) and its product prostaglandin E2 (PGE2) and the extent of pancreatic fibrosis. The aims of this study were to delineate the effects of PGE2 on immortalized human pancreatic stellate cells (HPSCs) and to identify the receptor involved. METHODS: Immunohistochemistry, reverse transcription- polymerase chain reaction and quantitative reverse transcription-polymerase chain reaction were used to assess COX-2, extracellular matrix, and matrix metalloproteinase gene expression. Eicosanoid profile was determined by liquid chromatography-tandem mass spectrometry. Human pancreatic stellate cell proliferation was assessed by MTS assay, migration by Boyden chamber assay, and invasion using an invasion chamber. Transient silencing was obtained by small interfering RNA. RESULTS: Human pancreatic stellate cells express COX-2 and synthesize PGE2. Prostaglandin E2 stimulated HPSC proliferation, migration, and invasion and stimulated expression of both extracellular matrix and matrix metalloproteinase genes. Human pancreatic stellate cells expressed all 4 EP receptors. Only blocking the EP4 receptor resulted in abrogation of PGE2-mediated HPSC activation. Specificity of EP4 for the effects of PGE2 on stellate cells was confirmed using specific antagonists. CONCLUSIONS: Our data indicate that PGE2 regulates pancreatic stellate cell profibrotic activities via EP4 receptor, thus suggesting EP4 receptor as useful therapeutic target for pancreatic cancer to reduce desmoplasia.",
keywords = "EP4 receptor, Pancreatic cancer, Pancreatic stellate cells, PGE",
author = "Chantale Charo and Vijaykumar Holla and Thiruvengadam Arumugam and Rosa Hwang and Peiying Yang and Dubois, {Raymond N.} and Menter, {David G.} and Logsdon, {Craig D.} and Vijaya Ramachandran",
year = "2013",
month = "4",
doi = "10.1097/MPA.0b013e318264d0f8",
language = "English (US)",
volume = "42",
pages = "467--474",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor

AU - Charo, Chantale

AU - Holla, Vijaykumar

AU - Arumugam, Thiruvengadam

AU - Hwang, Rosa

AU - Yang, Peiying

AU - Dubois, Raymond N.

AU - Menter, David G.

AU - Logsdon, Craig D.

AU - Ramachandran, Vijaya

PY - 2013/4

Y1 - 2013/4

N2 - OBJECTIVES: Pancreatic stellate cells are source of dense fibrotic stroma, a constant pathological feature of chronic pancreatitis and pancreatic adenocarcinoma. We observed correlation between levels of cyclooxygenase 2 (COX-2) and its product prostaglandin E2 (PGE2) and the extent of pancreatic fibrosis. The aims of this study were to delineate the effects of PGE2 on immortalized human pancreatic stellate cells (HPSCs) and to identify the receptor involved. METHODS: Immunohistochemistry, reverse transcription- polymerase chain reaction and quantitative reverse transcription-polymerase chain reaction were used to assess COX-2, extracellular matrix, and matrix metalloproteinase gene expression. Eicosanoid profile was determined by liquid chromatography-tandem mass spectrometry. Human pancreatic stellate cell proliferation was assessed by MTS assay, migration by Boyden chamber assay, and invasion using an invasion chamber. Transient silencing was obtained by small interfering RNA. RESULTS: Human pancreatic stellate cells express COX-2 and synthesize PGE2. Prostaglandin E2 stimulated HPSC proliferation, migration, and invasion and stimulated expression of both extracellular matrix and matrix metalloproteinase genes. Human pancreatic stellate cells expressed all 4 EP receptors. Only blocking the EP4 receptor resulted in abrogation of PGE2-mediated HPSC activation. Specificity of EP4 for the effects of PGE2 on stellate cells was confirmed using specific antagonists. CONCLUSIONS: Our data indicate that PGE2 regulates pancreatic stellate cell profibrotic activities via EP4 receptor, thus suggesting EP4 receptor as useful therapeutic target for pancreatic cancer to reduce desmoplasia.

AB - OBJECTIVES: Pancreatic stellate cells are source of dense fibrotic stroma, a constant pathological feature of chronic pancreatitis and pancreatic adenocarcinoma. We observed correlation between levels of cyclooxygenase 2 (COX-2) and its product prostaglandin E2 (PGE2) and the extent of pancreatic fibrosis. The aims of this study were to delineate the effects of PGE2 on immortalized human pancreatic stellate cells (HPSCs) and to identify the receptor involved. METHODS: Immunohistochemistry, reverse transcription- polymerase chain reaction and quantitative reverse transcription-polymerase chain reaction were used to assess COX-2, extracellular matrix, and matrix metalloproteinase gene expression. Eicosanoid profile was determined by liquid chromatography-tandem mass spectrometry. Human pancreatic stellate cell proliferation was assessed by MTS assay, migration by Boyden chamber assay, and invasion using an invasion chamber. Transient silencing was obtained by small interfering RNA. RESULTS: Human pancreatic stellate cells express COX-2 and synthesize PGE2. Prostaglandin E2 stimulated HPSC proliferation, migration, and invasion and stimulated expression of both extracellular matrix and matrix metalloproteinase genes. Human pancreatic stellate cells expressed all 4 EP receptors. Only blocking the EP4 receptor resulted in abrogation of PGE2-mediated HPSC activation. Specificity of EP4 for the effects of PGE2 on stellate cells was confirmed using specific antagonists. CONCLUSIONS: Our data indicate that PGE2 regulates pancreatic stellate cell profibrotic activities via EP4 receptor, thus suggesting EP4 receptor as useful therapeutic target for pancreatic cancer to reduce desmoplasia.

KW - EP4 receptor

KW - Pancreatic cancer

KW - Pancreatic stellate cells

KW - PGE

UR - http://www.scopus.com/inward/record.url?scp=84875465249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875465249&partnerID=8YFLogxK

U2 - 10.1097/MPA.0b013e318264d0f8

DO - 10.1097/MPA.0b013e318264d0f8

M3 - Article

VL - 42

SP - 467

EP - 474

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 3

ER -